p53 promotes adenoviral replication and increases late viral gene expression

Oncogene

Volumn 25, Issue 10, 2006, Pages 1509-1520

  Royds, J A ^a   Hibma, M ^a   Dix, B R ^a,c   Hananeia, L ^a   Russell, I A ^a   Wiles, A ^a   Wynford Thomas, D ^b   Braithwaite, A W ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Adenovirus; E1b55kDa; Oncology; p53

Indexed keywords

E1A PROTEIN; ONYX 015; PROTEIN P53;

ADENOVIRUS; ADENOVIRUS 5; ARTICLE; BIOASSAY; CELL DEATH; CELL STRAIN; CELL STRAIN A549; CELL STRAIN IIICF C; CELL STRAIN K1NEO; CELL STRAIN K1SCX; CELL STRAIN RKO; CELL STRAIN RKOP53.13; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LATE VIRUS GENE EXPRESSION; LATE VIRUS PROTEIN EXPRESSION; MAJOR LATE PROMOTER; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE ASSAY; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

ADENOVIRIDAE; ADENOVIRUS E1B PROTEINS; APOPTOSIS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; TUMOR SUPPRESSOR PROTEIN P53; VIRUS REPLICATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 33644833974     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209185     Document Type: Article

References (53)

1. Barker DD, Berk AJ. (1987). Virology 156: 107-121.
2. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, Muna M et al. (1996). Science 274: 373-376.
3. Braithwaite A, Nelson C, Skulimowski A, McGovern J, Pigott D, Jenkins J. (1990). Virology 177: 595-605.
4. Braithwaite AW, Murray JD, Bellett AJ. (1981). J Virol 39: 331-340.
5. Braithwaite AW, Sturzbecher HW, Addison C, Palmer C, Rudge K, Jenkins JR. (1987). Nature 329: 458-460.
6. Dix BR, Edwards SJ, Braithwaite AW. (2001). J Virol 75: 5443-5447.
7. Dix BR, O'Carroll SJ, Myers CJ, Edwards SJ, Braithwaite AW. (2000). Cancer Res 60: 2666-2672.
8. Edwards SJ, Dix BR, Myers CJ, Dobson-Le D, Huschtscha L, Hibma M et al. (2002). J Virol 76: 12483-12490.
9. Geoerger B, Grill J, Opolon P, Morizet J, Aubert G, Terrier-Lacombe MJ et al. (2002). Cancer Res 62: 764-772.
10. Goodrum FD, Ornelles DA. (1998). J Virol 72: 9479-9490.
11. Goodrum FD, Shenk T, Ornelles DA. (1996). J Virol 70: 6323-6335.
12. Hall AR, Dix BR, O'Carroll SJ, Braithwaite AW. (1998). Nat Med 4: 1068-1072.
13. Hann B, Balmain A. (2003). J Virol 77: 11588-11595.
14. Harada JN, Berk AJ. (1999). J Virol 73: 5333-5344.
15. Heise C, Sampson-Johannes A, Williams A, McCormick F, Von Hoff DD, Kirn DH. (1997). Nat Med 3: 639-645.
16. Hobom U, Dobbelstein M. (2004). J Virol 78: 7685-7697.
17. Holm PS, Bergmann S, Jurchott K, Lage H, Brand K, Ladhoff A et al. (2002). J Biol Chem 277: 10427-10434.
18. Jackson P, Ridgway P, Rayner J, Noble J, Braithwaite A. (1994). Biochem Biophys Res Commun 203: 133-140.
19. Jones N, Shenk T. (1978). Cell 13: 181-188.
20. Jones N, Shenk T. (1979). Proc Natl Acad Sci USA 76: 3665-3669.
21. Koch P, Gatfield J, Lober C, Hobom U, Lenz-Stoppler C, Roth J et al. (2001). Cancer Res 61: 5941-5947.
22. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. (2003). BioEssays 25: 691-698.
23. Kruijer W, van Schaik FM, Sussenbach JS. (1981). Nucleic Acids Res 9: 4439-4457.
24. Lee H, Kim J, Lee B, Chang JW, Ahn J, Park JO et al. (2000). Int J Cancer 88: 454-463.
25. Lehman TA, Bennett WP, Metcalf RA, Welsh JA, Ecker J, Modali RV et al. (1991). Cancer Res 51: 4090-4096.
26. Morris GF, Mathews MB. (1991). J Virol 65: 6397-6406.
27. Nemunaitis J, Ganly I, Khuri F, Arseneau J, Kuhn J, McCarty T et al. (2000). Cancer Res 60: 6359-6366.
28. Nemunaitis J, Khuri F, Ganly I, Arseneau J, Posner M, Vokes E et al. (2001). J Clin Oncol 19: 289-298.
29. O'Carroll SJ, Hall AR, Myers CJ, Braithwaite AW, Dix BR. (2000). Biotechniques 28: 408-410.
30. O'Shea CC, Johnson L, Bagus B, Choi S, Nicholas C, Shen A et al. (2004). Cancer Cell 6: 611-623.
31. Ory K, Legros Y, Auguin C, Soussi T. (1994). EMBO J 13: 3496-3504.
32. Parks CL, Shenk T. (1997). J Virol 71: 9600-9607.
33. Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L et al. (1998). Cell 92: 713-723.
34. Prives C, Hall PA. (1999). J Pathol 187: 112-126.
35. Querido E, Blanchette P, Yan Q, Kamura T, Morrison M, Boivin D et al. (2001a). Genes Dev 15: 3104-3117.
36. Querido E, Morrison MR, Chu-Pham-Dang H, Thirlwell SW, Boivin D, Branton PE. (2001b). J Virol 75: 699-709.
37. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V et al. (2002). Cancer Res 62: 3812-3818.
38. Ries SJ, Brandts CH, Chung AS, Biederer CH, Hann BC, Lipner EM et al. (2000). Nat Med 6: 1128-1133.
39. Rogan EM, Bryan TM, Hukku B, Maclean K, Chang AC, Moy EL et al. (1995). Mol Cell Biol 15: 4745-4753.
40. Rogulski KR, Freytag SO, Zhang K, Gilbert JD, Paielli DL, Kim JH et al. (2000). Cancer Res 60: 1193-1196.
41. Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, Zur Hausen H. (1998). J Virol 72: 9470-9478.
42. Sarnow P, Sullivan CA, Levine AJ. (1982). Virology 120: 510-517.
43. Sauthoff H, Pipiya T, Heitner S, Chen S, Norman R, Rom W et al. (2002). Hum Gene Ther 13: 1859-1871.
44. Scheffner M, Munger K, Byrne J, Howley P. (1991). Proc Natl Acad Sci USA 88: 5523-5527.
45. Shenk T. (1996) In: Fields B, Knipe D, Howley P, Chanock R, Melnick J, Monath T, Roizman B, Strauss S (eds). Virology vol. 2. Lippincott-Raven: Philadelphia. pp 2111-2148.
46. Sleigh MJ. (1986). Anal Biochem 156: 251-256.
47. Slichenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. (1993). Cancer Res 53: 4164-4168.
48. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S et al. (1998). EMBO J 17: 5001-5014.
49. Weyer U, Doerfler W. (1985). EMBO J 4: 3015-3019.
50. Williams J, Young C, Austin P. (1974). Cold Spring Harbor Sympos Quant Biol 39: 427-437.
51. Wyllie FS, Haughton MF, Rowson JM, Wynford-Thomas D. (1999). Br J Cancer 79: 1111-1120.
52. Yew PR, Berk AJ. (1992). Nature 357: 82-85.
53. Zhang YF, Homer C, Edwards SJ, Hananeia L, Lasham A, Royds J et al. (2003). Oncogene 22: 2782-2794.